These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
309 related articles for article (PubMed ID: 12679522)
1. Identification of a small molecule inhibitor of the hedgehog signaling pathway: effects on basal cell carcinoma-like lesions. Williams JA; Guicherit OM; Zaharian BI; Xu Y; Chai L; Wichterle H; Kon C; Gatchalian C; Porter JA; Rubin LL; Wang FY Proc Natl Acad Sci U S A; 2003 Apr; 100(8):4616-21. PubMed ID: 12679522 [TBL] [Abstract][Full Text] [Related]
2. Hedgehog signaling pathway as a target for therapeutic intervention in basal cell carcinoma. Williams JA Drug News Perspect; 2003 Dec; 16(10):657-62. PubMed ID: 14747845 [TBL] [Abstract][Full Text] [Related]
3. Antitumoral effects of calcitriol in basal cell carcinomas involve inhibition of hedgehog signaling and induction of vitamin D receptor signaling and differentiation. Uhmann A; Niemann H; Lammering B; Henkel C; Hess I; Nitzki F; Fritsch A; Prüfer N; Rosenberger A; Dullin C; Schraepler A; Reifenberger J; Schweyer S; Pietsch T; Strutz F; Schulz-Schaeffer W; Hahn H Mol Cancer Ther; 2011 Nov; 10(11):2179-88. PubMed ID: 21878656 [TBL] [Abstract][Full Text] [Related]
4. Correlations between the Sonic Hedgehog pathway and basal cell carcinoma. Lupi O Int J Dermatol; 2007 Nov; 46(11):1113-7. PubMed ID: 17988327 [TBL] [Abstract][Full Text] [Related]
5. Small-molecule modulators of Hedgehog signaling: identification and characterization of Smoothened agonists and antagonists. Frank-Kamenetsky M; Zhang XM; Bottega S; Guicherit O; Wichterle H; Dudek H; Bumcrot D; Wang FY; Jones S; Shulok J; Rubin LL; Porter JA J Biol; 2002 Nov; 1(2):10. PubMed ID: 12437772 [TBL] [Abstract][Full Text] [Related]
6. Posaconazole, a Second-Generation Triazole Antifungal Drug, Inhibits the Hedgehog Signaling Pathway and Progression of Basal Cell Carcinoma. Chen B; Trang V; Lee A; Williams NS; Wilson AN; Epstein EH; Tang JY; Kim J Mol Cancer Ther; 2016 May; 15(5):866-76. PubMed ID: 26823493 [TBL] [Abstract][Full Text] [Related]
8. Basal cell carcinoma and its development: insights from radiation-induced tumors in Ptch1-deficient mice. Mancuso M; Pazzaglia S; Tanori M; Hahn H; Merola P; Rebessi S; Atkinson MJ; Di Majo V; Covelli V; Saran A Cancer Res; 2004 Feb; 64(3):934-41. PubMed ID: 14871823 [TBL] [Abstract][Full Text] [Related]
9. Synergistic cross-talk of hedgehog and interleukin-6 signaling drives growth of basal cell carcinoma. Sternberg C; Gruber W; Eberl M; Tesanovic S; Stadler M; Elmer DP; Schlederer M; Grund S; Roos S; Wolff F; Kaur S; Mangelberger D; Lehrach H; Hache H; Wierling C; Laimer J; Lackner P; Wiederstein M; Kasper M; Risch A; Petzelbauer P; Moriggl R; Kenner L; Aberger F Int J Cancer; 2018 Dec; 143(11):2943-2954. PubMed ID: 29987839 [TBL] [Abstract][Full Text] [Related]
10. Inhibition of smoothened signaling prevents ultraviolet B-induced basal cell carcinomas through regulation of Fas expression and apoptosis. Athar M; Li C; Tang X; Chi S; Zhang X; Kim AL; Tyring SK; Kopelovich L; Hebert J; Epstein EH; Bickers DR; Xie J Cancer Res; 2004 Oct; 64(20):7545-52. PubMed ID: 15492281 [TBL] [Abstract][Full Text] [Related]
11. Interaction of hedgehog and vitamin D signaling pathways in basal cell carcinomas. Albert B; Hahn H Adv Exp Med Biol; 2014; 810():329-41. PubMed ID: 25207374 [TBL] [Abstract][Full Text] [Related]
13. Topical treatment of Basal cell carcinomas in nevoid Basal cell carcinoma syndrome with a smoothened inhibitor. Skvara H; Kalthoff F; Meingassner JG; Wolff-Winiski B; Aschauer H; Kelleher JF; Wu X; Pan S; Mickel L; Schuster C; Stary G; Jalili A; David OJ; Emotte C; Antunes AM; Rose K; Decker J; Carlson I; Gardner H; Stuetz A; Bertolino AP; Stingl G; De Rie MA J Invest Dermatol; 2011 Aug; 131(8):1735-44. PubMed ID: 21430703 [TBL] [Abstract][Full Text] [Related]
14. Advances in the treatment of Basal cell carcinoma: Hedgehog inhibitors. Kudchadkar R; Lewis K; Gonzalez R Semin Oncol; 2012 Apr; 39(2):139-44. PubMed ID: 22484185 [TBL] [Abstract][Full Text] [Related]
15. INTU is essential for oncogenic Hh signaling through regulating primary cilia formation in basal cell carcinoma. Yang N; Leung EL; Liu C; Li L; Eguether T; Jun Yao XJ; Jones EC; Norris DA; Liu A; Clark RA; Roop DR; Pazour GJ; Shroyer KR; Chen J Oncogene; 2017 Aug; 36(35):4997-5005. PubMed ID: 28459465 [TBL] [Abstract][Full Text] [Related]
16. Targeting superficial or nodular Basal cell carcinoma with topically formulated small molecule inhibitor of smoothened. Tang T; Tang JY; Li D; Reich M; Callahan CA; Fu L; Yauch RL; Wang F; Kotkow K; Chang KS; Shpall E; Wu A; Rubin LL; Marsters JC; Epstein EH; Caro I; de Sauvage FJ Clin Cancer Res; 2011 May; 17(10):3378-87. PubMed ID: 21558397 [TBL] [Abstract][Full Text] [Related]
17. Targeting the hedgehog signaling pathway with small molecules. Kiselyov AS Anticancer Agents Med Chem; 2006 Sep; 6(5):445-9. PubMed ID: 17017853 [TBL] [Abstract][Full Text] [Related]
18. Effects of oncogenic mutations in Smoothened and Patched can be reversed by cyclopamine. Taipale J; Chen JK; Cooper MK; Wang B; Mann RK; Milenkovic L; Scott MP; Beachy PA Nature; 2000 Aug; 406(6799):1005-9. PubMed ID: 10984056 [TBL] [Abstract][Full Text] [Related]
19. Sheep, lilies and human genetics. Bale AE Nature; 2000 Aug; 406(6799):944-5. PubMed ID: 10984033 [No Abstract] [Full Text] [Related]